{"protocolSection": {"identificationModule": {"nctId": "NCT03215758", "orgStudyIdInfo": {"id": "CQAW039A2316"}, "secondaryIdInfos": [{"id": "2017-001273-16", "type": "EUDRACT_NUMBER"}], "organization": {"fullName": "Novartis", "class": "INDUSTRY"}, "briefTitle": "Study of Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled Asthma", "officialTitle": "A 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled Asthma"}, "statusModule": {"statusVerifiedDate": "2021-10", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2017-11-01", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2019-07-02", "type": "ACTUAL"}, "completionDateStruct": {"date": "2019-07-30", "type": "ACTUAL"}, "studyFirstSubmitDate": "2017-07-11", "studyFirstSubmitQcDate": "2017-07-11", "studyFirstPostDateStruct": {"date": "2017-07-12", "type": "ACTUAL"}, "resultsFirstSubmitDate": "2020-01-30", "resultsFirstSubmitQcDate": "2020-01-30", "resultsFirstPostDateStruct": {"date": "2020-02-12", "type": "ACTUAL"}, "dispFirstSubmitDate": "2019-07-26", "dispFirstSubmitQcDate": "2019-07-26", "dispFirstPostDateStruct": {"date": "2019-08-02", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2021-10-06", "lastUpdatePostDateStruct": {"date": "2021-10-07", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Novartis Pharmaceuticals", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": true, "isFdaRegulatedDrug": true, "isFdaRegulatedDevice": false}, "descriptionModule": {"briefSummary": "A randomized, multicenter, double-blind, placebo- controlled parallel-group study to determine the efficacy and safety of QAW039, compared with placebo, when added to standard-of-care (SoC) asthma therapy in adult and adolescent (\u2265 12 years) patients with uncontrolled asthma with respect to change from baseline in forced expiratory volume in 1 second (FEV1) at the end of 12 weeks of treatment."}, "conditionsModule": {"conditions": ["Asthma"], "keywords": ["QAW039, uncontrolled asthma"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE3"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "DOUBLE", "whoMasked": ["PARTICIPANT", "INVESTIGATOR"]}}, "enrollmentInfo": {"count": 675, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "QAW039", "type": "ACTIVE_COMPARATOR", "description": "QAW039 once daily", "interventionNames": ["Drug: QAW039"]}, {"label": "Placebo", "type": "PLACEBO_COMPARATOR", "description": "Placebo once daily", "interventionNames": ["Drug: Placebo"]}], "interventions": [{"type": "DRUG", "name": "QAW039", "description": "QAW039 once daily", "armGroupLabels": ["QAW039"]}, {"type": "DRUG", "name": "Placebo", "description": "Placebo once daily", "armGroupLabels": ["Placebo"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Change From Baseline in Pre-dose FEV1 at Week 12", "description": "Forced Expiratory Volume in one second (FEV1) is calculated as the volume of air forcibly exhaled in one second as measured by a spirometer. Baseline is defined as the last available FEV1 measurement taken prior to the first dose of randomized study drug.", "timeFrame": "Week 12"}], "secondaryOutcomes": [{"measure": "Change From Baseline in Daytime Asthma Symptom Score", "description": "Daytime asthma symptoms are evaluated through four questions and each of them will be rated on a scale of 0 to 6. Higher scores indicate more severe asthma-related symptoms. A mean score will be calculated for the responses to 4 questions.", "timeFrame": "12 weeks"}, {"measure": "Change From Baseline in Daily Use of SABA", "description": "Daily use of SABA (the number of rescue medication puffs taken in the previous 12 hours) was recorded using a patient electronic diary (referred to as eDiary or eDiary/ePEF). Patients were instructed to routinely complete the patient diary twice daily - at the same time each morning and each evening, approximately 12 hours apart.", "timeFrame": "12 weeks"}, {"measure": "Change From Baseline in Asthma Quality of Life (AQLQ+12) Score", "description": "AQLQ is a 32-item instrument administered as a self-assessment. AQLQ+12 is a modified version of AQLQ developed to measure functional impairments of participants aged 12-70 years. It is divided into 4 domains: activity limitation, symptoms, emotional function, and environmental stimuli. Participants were asked to recall their experiences during the last 2 weeks and respond to each question on a 7-point scale (1=severe impairment, 7=no impairment), where higher scores indicated \"better quality of life.\" Overall AQLQ+12 score is the mean of all 32 responses.", "timeFrame": "Week 12"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* A diagnosis of asthma (according to GINA 2016) for a period of at least 6 months.\n* Treated with medium dose inhaled corticosteroid (ICS), or high dose ICS, or low dose ICS plus long- acting beta agonist (LABA), or low dose ICS plus leukotriene receptor antagonist (LTRA), or medium dose ICS plus LABA for at least 3 months prior to Visit 1 and the doses have been stable for at least 4 weeks prior to Visit 1.\n* FEV1 of \u226485% for patients aged \u226518 years. FEV1 of \u226490% for patients aged 12 to \\<18 years.\n* Daytime asthma symptom score (0 to 6 scale) of \u22651 per day during 4 of the last 7 days of the placebo run- in period.\n* Total daily SABA use \u22651 puff per day during 4 of the last 7 days of the placebo run-in period.\n* Demonstrated reversible airway obstruction.\n* Asthma control questionnaire (ACQ) score \u2265 1.5.\n\nExclusion Criteria:\n\n* Use of other investigational drugs within 5 half-lives of enrollment, or within 30 days, whichever is longer.\n* A resting QTcF (Fridericia) \u2265450 msec (male) or\n\n  \u2265460 msec (female).\n* Pregnant or nursing (lactating) women.\n* Serious co-morbidities.\n* Patients on \\>20 mg of simvastatin, \\> 40 mg of atorvastatin, \\>40 mg of pravastatin, or \\>2 mg of pitavastatin.\n\nOther protocol-defined inclusion/exclusion criteria may apply.", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "12 Years", "stdAges": ["CHILD", "ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"locations": [{"facility": "Novartis Investigative Site", "city": "Flagstaff", "state": "Arizona", "zip": "86001", "country": "United States", "geoPoint": {"lat": 35.19807, "lon": -111.65127}}, {"facility": "Novartis Investigative Site", "city": "Phoenix", "state": "Arizona", "zip": "85006", "country": "United States", "geoPoint": {"lat": 33.44838, "lon": -112.07404}}, {"facility": "Novartis Investigative Site", "city": "Huntington Beach", "state": "California", "zip": "92647", "country": "United States", "geoPoint": {"lat": 33.6603, "lon": -117.99923}}, {"facility": "Novartis Investigative Site", "city": "Long Beach", "state": "California", "zip": "90808", "country": "United States", "geoPoint": {"lat": 33.76696, "lon": -118.18923}}, {"facility": "Novartis Investigative Site", "city": "Los Angeles", "state": "California", "zip": "90025", "country": "United States", "geoPoint": {"lat": 34.05223, "lon": -118.24368}}, {"facility": "Novartis Investigative Site", "city": "Mission Viejo", "state": "California", "zip": "92691", "country": "United States", "geoPoint": {"lat": 33.60002, "lon": -117.672}}, {"facility": "Novartis Investigative Site", "city": "Mountain View", "state": "California", "zip": "94040", "country": "United States", "geoPoint": {"lat": 37.38605, "lon": -122.08385}}, {"facility": "Novartis Investigative Site", "city": "Orange", "state": "California", "zip": "92868", "country": "United States", "geoPoint": {"lat": 33.78779, "lon": -117.85311}}, {"facility": "Novartis Investigative Site", "city": "Roseville", "state": "California", "zip": "95661", "country": "United States", "geoPoint": {"lat": 38.75212, "lon": -121.28801}}, {"facility": "Novartis Investigative Site", "city": "Walnut Creek", "state": "California", "zip": "94598", "country": "United States", "geoPoint": {"lat": 37.90631, "lon": -122.06496}}, {"facility": "Novartis Investigative Site", "city": "Denver", "state": "Colorado", "zip": "80206", "country": "United States", "geoPoint": {"lat": 39.73915, "lon": -104.9847}}, {"facility": "Novartis Investigative Site", "city": "Tamarac", "state": "Florida", "zip": "33321", "country": "United States", "geoPoint": {"lat": 26.21286, "lon": -80.24977}}, {"facility": "Novartis Investigative Site", "city": "Winter Park", "state": "Florida", "zip": "32789", "country": "United States", "geoPoint": {"lat": 28.6, "lon": -81.33924}}, {"facility": "Novartis Investigative Site", "city": "Albany", "state": "Georgia", "zip": "31707", "country": "United States", "geoPoint": {"lat": 31.57851, "lon": -84.15574}}, {"facility": "Novartis Investigative Site", "city": "Dacula", "state": "Georgia", "zip": "30019", "country": "United States", "geoPoint": {"lat": 33.98872, "lon": -83.89796}}, {"facility": "Novartis Investigative Site", "city": "Honolulu", "state": "Hawaii", "zip": "96814", "country": "United States", "geoPoint": {"lat": 21.30694, "lon": -157.85833}}, {"facility": "Novartis Investigative Site", "city": "Lihue", "state": "Hawaii", "zip": "96766", "country": "United States", "geoPoint": {"lat": 21.98121, "lon": -159.3721}}, {"facility": "Novartis Investigative Site", "city": "Overland Park", "state": "Kansas", "zip": "66210", "country": "United States", "geoPoint": {"lat": 38.98223, "lon": -94.67079}}, {"facility": "Novartis Investigative Site", "city": "Louisville", "state": "Kentucky", "zip": "40215", "country": "United States", "geoPoint": {"lat": 38.25424, "lon": -85.75941}}, {"facility": "Novartis Investigative Site", "city": "Columbia", "state": "Missouri", "zip": "65203", "country": "United States", "geoPoint": {"lat": 38.95171, "lon": -92.33407}}, {"facility": "Novartis Investigative Site", "city": "Rolla", "state": "Missouri", "zip": "65401", "country": "United States", "geoPoint": {"lat": 37.95143, "lon": -91.77127}}, {"facility": "Novartis Investigative Site", "city": "Missoula", "state": "Montana", "zip": "59808", "country": "United States", "geoPoint": {"lat": 46.87215, "lon": -113.994}}, {"facility": "Novartis Investigative Site", "city": "Bellevue", "state": "Nebraska", "zip": "68123", "country": "United States", "geoPoint": {"lat": 41.13667, "lon": -95.89084}}, {"facility": "Novartis Investigative Site", "city": "La Vista", "state": "Nebraska", "zip": "68128", "country": "United States", "geoPoint": {"lat": 41.18389, "lon": -96.03113}}, {"facility": "Novartis Investigative Site", "city": "Skillman", "state": "New Jersey", "zip": "08558", "country": "United States", "geoPoint": {"lat": 40.42011, "lon": -74.7146}}, {"facility": "Novartis Investigative Site", "city": "Asheville", "state": "North Carolina", "zip": "28801", "country": "United States", "geoPoint": {"lat": 35.60095, "lon": -82.55402}}, {"facility": "Novartis Investigative Site", "city": "Gastonia", "state": "North Carolina", "zip": "28054", "country": "United States", "geoPoint": {"lat": 35.26208, "lon": -81.1873}}, {"facility": "Novartis Investigative Site", "city": "High Point", "state": "North Carolina", "zip": "27262", "country": "United States", "geoPoint": {"lat": 35.95569, "lon": -80.00532}}, {"facility": "Novartis Investigative Site", "city": "Cincinnati", "state": "Ohio", "zip": "45231", "country": "United States", "geoPoint": {"lat": 39.12713, "lon": -84.51435}}, {"facility": "Novartis Investigative Site", "city": "Edmond", "state": "Oklahoma", "zip": "73034", "country": "United States", "geoPoint": {"lat": 35.65283, "lon": -97.4781}}, {"facility": "Novartis Investigative Site", "city": "Eugene", "state": "Oregon", "zip": "97401-4043", "country": "United States", "geoPoint": {"lat": 44.05207, "lon": -123.08675}}, {"facility": "Novartis Investigative Site", "city": "Medford", "state": "Oregon", "zip": "97504", "country": "United States", "geoPoint": {"lat": 42.32652, "lon": -122.87559}}, {"facility": "Novartis Investigative Site", "city": "Portland", "state": "Oregon", "zip": "97213", "country": "United States", "geoPoint": {"lat": 45.52345, "lon": -122.67621}}, {"facility": "Novartis Investigative Site", "city": "Portland", "state": "Oregon", "zip": "97220", "country": "United States", "geoPoint": {"lat": 45.52345, "lon": -122.67621}}, {"facility": "Novartis Investigative Site", "city": "Rapid City", "state": "South Dakota", "zip": "57701", "country": "United States", "geoPoint": {"lat": 44.08054, "lon": -103.23101}}, {"facility": "Novartis Investigative Site", "city": "Boerne", "state": "Texas", "zip": "78006", "country": "United States", "geoPoint": {"lat": 29.79466, "lon": -98.73197}}, {"facility": "Novartis Investigative Site", "city": "Dallas", "state": "Texas", "zip": "75231", "country": "United States", "geoPoint": {"lat": 32.78306, "lon": -96.80667}}, {"facility": "Novartis Investigative Site", "city": "El Paso", "state": "Texas", "zip": "79903", "country": "United States", "geoPoint": {"lat": 31.75872, "lon": -106.48693}}, {"facility": "Novartis Investigative Site", "city": "Fort Worth", "state": "Texas", "zip": "76109", "country": "United States", "geoPoint": {"lat": 32.72541, "lon": -97.32085}}, {"facility": "Novartis Investigative Site", "city": "McKinney", "state": "Texas", "zip": "75069", "country": "United States", "geoPoint": {"lat": 33.19762, "lon": -96.61527}}, {"facility": "Novartis Investigative Site", "city": "Seattle", "state": "Washington", "zip": "98122-4379", "country": "United States", "geoPoint": {"lat": 47.60621, "lon": -122.33207}}, {"facility": "Novartis Investigative Site", "city": "Greenfield", "state": "Wisconsin", "zip": "53228", "country": "United States", "geoPoint": {"lat": 42.9614, "lon": -88.01259}}, {"facility": "Novartis Investigative Site", "city": "Berazategui", "state": "Buenos Aires", "zip": "1888", "country": "Argentina", "geoPoint": {"lat": -34.76531, "lon": -58.21278}}, {"facility": "Novartis Investigative Site", "city": "Caba", "state": "Buenos Aires", "zip": "C1056ABJ", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"facility": "Novartis Investigative Site", "city": "Caba", "state": "Buenos Aires", "zip": "C1122AAK", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"facility": "Novartis Investigative Site", "city": "Caba", "state": "Buenos Aires", "zip": "C1425BEN", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"facility": "Novartis Investigative Site", "city": "Caba", "state": "Buenos Aires", "zip": "C1426ABP", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"facility": "Novartis Investigative Site", "city": "Lanus", "state": "Buenos Aires", "zip": "B8000XAV", "country": "Argentina", "geoPoint": {"lat": -34.70252, "lon": -58.3955}}, {"facility": "Novartis Investigative Site", "city": "Mar del Plata", "state": "Buenos Aires", "zip": "7600", "country": "Argentina", "geoPoint": {"lat": -38.00228, "lon": -57.55754}}, {"facility": "Novartis Investigative Site", "city": "Santa Rosa", "state": "La Pampa", "zip": "6300", "country": "Argentina", "geoPoint": {"lat": -36.61667, "lon": -64.28333}}, {"facility": "Novartis Investigative Site", "city": "Buenos Aires", "state": "Nueve De Julio", "zip": "B6500BWQ", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"facility": "Novartis Investigative Site", "city": "Santa Fe", "state": "Rosario", "zip": "S2000DBS", "country": "Argentina", "geoPoint": {"lat": -31.63333, "lon": -60.7}}, {"facility": "Novartis Investigative Site", "city": "Rosario", "state": "Santa Fe", "zip": "S2000BRH", "country": "Argentina", "geoPoint": {"lat": -32.94682, "lon": -60.63932}}, {"facility": "Novartis Investigative Site", "city": "Rosario", "state": "Santa Fe", "zip": "S2000JKR", "country": "Argentina", "geoPoint": {"lat": -32.94682, "lon": -60.63932}}, {"facility": "Novartis Investigative Site", "city": "San Miguel de Tucuman", "state": "Tucuman", "zip": "4000", "country": "Argentina", "geoPoint": {"lat": -26.82414, "lon": -65.2226}}, {"facility": "Novartis Investigative Site", "city": "San Miguel de Tucuman", "state": "Tucuman", "zip": "T4000IFL", "country": "Argentina", "geoPoint": {"lat": -26.82414, "lon": -65.2226}}, {"facility": "Novartis Investigative Site", "city": "Buenos Aires", "zip": "C1012AAR", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"facility": "Novartis Investigative Site", "city": "Buenos Aires", "zip": "C1125ABE", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"facility": "Novartis Investigative Site", "city": "Cordoba", "zip": "X5003DCE", "country": "Argentina", "geoPoint": {"lat": -31.4135, "lon": -64.18105}}, {"facility": "Novartis Investigative Site", "city": "Mendoza", "zip": "5500", "country": "Argentina", "geoPoint": {"lat": -32.89084, "lon": -68.82717}}, {"facility": "Novartis Investigative Site", "city": "Mendoza", "zip": "M5500CBA", "country": "Argentina", "geoPoint": {"lat": -32.89084, "lon": -68.82717}}, {"facility": "Novartis Investigative Site", "city": "Salta", "zip": "4000", "country": "Argentina", "geoPoint": {"lat": -24.7859, "lon": -65.41166}}, {"facility": "Novartis Investigative Site", "city": "Peine", "state": "Niedersachsen", "zip": "31224", "country": "Germany", "geoPoint": {"lat": 52.31928, "lon": 10.2352}}, {"facility": "Novartis Investigative Site", "city": "Cottbus", "state": "Sachsen", "zip": "03050", "country": "Germany", "geoPoint": {"lat": 51.75769, "lon": 14.32888}}, {"facility": "Novartis Investigative Site", "city": "Aschaffenburg", "zip": "63739", "country": "Germany", "geoPoint": {"lat": 49.97704, "lon": 9.15214}}, {"facility": "Novartis Investigative Site", "city": "Bamberg", "zip": "96049", "country": "Germany", "geoPoint": {"lat": 49.89873, "lon": 10.90067}}, {"facility": "Novartis Investigative Site", "city": "Berlin", "zip": "12157", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "Novartis Investigative Site", "city": "Berlin", "zip": "12203", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "Novartis Investigative Site", "city": "Furstenwalde", "zip": "15517", "country": "Germany", "geoPoint": {"lat": 52.36067, "lon": 14.06185}}, {"facility": "Novartis Investigative Site", "city": "Gauting", "zip": "82131", "country": "Germany", "geoPoint": {"lat": 48.06919, "lon": 11.37703}}, {"facility": "Novartis Investigative Site", "city": "Leipzig", "zip": "04275", "country": "Germany", "geoPoint": {"lat": 51.33962, "lon": 12.37129}}, {"facility": "Novartis Investigative Site", "city": "Lubeck", "zip": "23552", "country": "Germany", "geoPoint": {"lat": 53.86893, "lon": 10.68729}}, {"facility": "Novartis Investigative Site", "city": "Prien A Chiemsee", "zip": "83209", "country": "Germany"}, {"facility": "Novartis Investigative Site", "city": "Rudersdorf", "zip": "15562", "country": "Germany", "geoPoint": {"lat": 51.1, "lon": 11.45}}, {"facility": "Novartis Investigative Site", "city": "Schleswig", "zip": "24837", "country": "Germany", "geoPoint": {"lat": 54.52156, "lon": 9.5586}}, {"facility": "Novartis Investigative Site", "city": "Schwerin", "zip": "19055", "country": "Germany", "geoPoint": {"lat": 53.62937, "lon": 11.41316}}, {"facility": "Novartis Investigative Site", "city": "Witten", "zip": "58452", "country": "Germany", "geoPoint": {"lat": 51.44362, "lon": 7.35258}}, {"facility": "Novartis Investigative Site", "city": "Budaors", "state": "HUN", "zip": "2040", "country": "Hungary", "geoPoint": {"lat": 47.46181, "lon": 18.95845}}, {"facility": "Novartis Investigative Site", "city": "Ajka", "zip": "8400", "country": "Hungary", "geoPoint": {"lat": 47.10196, "lon": 17.55892}}, {"facility": "Novartis Investigative Site", "city": "Budapest", "zip": "1125", "country": "Hungary", "geoPoint": {"lat": 47.49801, "lon": 19.03991}}, {"facility": "Novartis Investigative Site", "city": "Debrecen", "zip": "4032", "country": "Hungary", "geoPoint": {"lat": 47.53333, "lon": 21.63333}}, {"facility": "Novartis Investigative Site", "city": "Godollo", "zip": "2100", "country": "Hungary", "geoPoint": {"lat": 47.59657, "lon": 19.35515}}, {"facility": "Novartis Investigative Site", "city": "Szeged", "zip": "6722", "country": "Hungary", "geoPoint": {"lat": 46.253, "lon": 20.14824}}, {"facility": "Novartis Investigative Site", "city": "Culiacan", "state": "Sinaloa", "zip": "80230", "country": "Mexico", "geoPoint": {"lat": 24.79032, "lon": -107.38782}}, {"facility": "Novartis Investigative Site", "city": "Rio De Janeiro", "zip": "06700", "country": "Mexico", "geoPoint": {"lat": 16.11278, "lon": -91.5425}}, {"facility": "Novartis Investigative Site", "city": "Lipa City", "state": "Batangas", "zip": "4217", "country": "Philippines", "geoPoint": {"lat": 13.9411, "lon": 121.1631}}, {"facility": "Novartis Investigative Site", "city": "Quezon City", "state": "Manila", "zip": "1100", "country": "Philippines", "geoPoint": {"lat": 14.6488, "lon": 121.0509}}, {"facility": "Novartis Investigative Site", "city": "Iloilo City", "zip": "5000", "country": "Philippines", "geoPoint": {"lat": 10.69694, "lon": 122.56444}}, {"facility": "Novartis Investigative Site", "city": "Manila", "zip": "1000", "country": "Philippines", "geoPoint": {"lat": 14.6042, "lon": 120.9822}}, {"facility": "Novartis Investigative Site", "city": "Riyadh", "state": "SAU", "zip": "11525", "country": "Saudi Arabia", "geoPoint": {"lat": 24.68773, "lon": 46.72185}}, {"facility": "Novartis Investigative Site", "city": "Jeddah", "zip": "21423", "country": "Saudi Arabia", "geoPoint": {"lat": 21.54238, "lon": 39.19797}}, {"facility": "Novartis Investigative Site", "city": "Bardejov", "state": "Slovak Republic", "zip": "085 01", "country": "Slovakia", "geoPoint": {"lat": 49.29175, "lon": 21.27271}}, {"facility": "Novartis Investigative Site", "city": "Kezmarok", "zip": "060 01", "country": "Slovakia", "geoPoint": {"lat": 49.13571, "lon": 20.43352}}, {"facility": "Novartis Investigative Site", "city": "Michalovce", "zip": "071 01", "country": "Slovakia", "geoPoint": {"lat": 48.75434, "lon": 21.9195}}, {"facility": "Novartis Investigative Site", "city": "Poprad", "zip": "058 01", "country": "Slovakia", "geoPoint": {"lat": 49.06144, "lon": 20.29798}}, {"facility": "Novartis Investigative Site", "city": "Presov", "zip": "080 01", "country": "Slovakia", "geoPoint": {"lat": 48.99839, "lon": 21.23393}}, {"facility": "Novartis Investigative Site", "city": "Spisska Nova Ves", "zip": "052 01", "country": "Slovakia", "geoPoint": {"lat": 48.94464, "lon": 20.56153}}, {"facility": "Novartis Investigative Site", "city": "Zilina", "zip": "01207", "country": "Slovakia", "geoPoint": {"lat": 49.22315, "lon": 18.73941}}, {"facility": "Novartis Investigative Site", "city": "Tygerberg", "state": "Cape Town", "zip": "7505", "country": "South Africa"}, {"facility": "Novartis Investigative Site", "city": "Cape Town", "zip": "7500", "country": "South Africa", "geoPoint": {"lat": -33.92584, "lon": 18.42322}}, {"facility": "Novartis Investigative Site", "city": "Chatsworth", "zip": "4092", "country": "South Africa", "geoPoint": {"lat": -33.54778, "lon": 18.58201}}, {"facility": "Novartis Investigative Site", "city": "Durban", "zip": "4001", "country": "South Africa", "geoPoint": {"lat": -29.8579, "lon": 31.0292}}, {"facility": "Novartis Investigative Site", "city": "Pretoria", "zip": "0183", "country": "South Africa", "geoPoint": {"lat": -25.74486, "lon": 28.18783}}, {"facility": "Novartis Investigative Site", "city": "Istanbul", "state": "TUR", "zip": "34098", "country": "Turkey", "geoPoint": {"lat": 41.01384, "lon": 28.94966}}, {"facility": "Novartis Investigative Site", "city": "Adana", "zip": "01330", "country": "Turkey", "geoPoint": {"lat": 37.00167, "lon": 35.32889}}, {"facility": "Novartis Investigative Site", "city": "Ankara", "zip": "06100", "country": "Turkey", "geoPoint": {"lat": 39.91987, "lon": 32.85427}}, {"facility": "Novartis Investigative Site", "city": "Istanbul", "zip": "34020", "country": "Turkey", "geoPoint": {"lat": 41.01384, "lon": 28.94966}}, {"facility": "Novartis Investigative Site", "city": "Mersin", "zip": "33343", "country": "Turkey", "geoPoint": {"lat": 36.79526, "lon": 34.61792}}, {"facility": "Novartis Investigative Site", "city": "Talas / Kayseri", "zip": "38039", "country": "Turkey"}, {"facility": "Novartis Investigative Site", "city": "Yenisehir/Izmir", "zip": "35110", "country": "Turkey"}]}, "referencesModule": {"seeAlsoLinks": [{"label": "A Plain Language Trial Summary is available on novartisclinicaltrials.com", "url": "https://www.novctrd.com/ctrdweb/patientsummary/patientsummaries?patientSummaryId=593"}]}}, "resultsSection": {"participantFlowModule": {"recruitmentDetails": "Participants were recruited from centers in Argentina (20), Germany (12), Hungary (4), Mexico (2), Philippines (4), Slovakia (7), South Africa (5), Turkey (5), United States (29)", "groups": [{"id": "FG000", "title": "QAW039", "description": "QAW039 once daily"}, {"id": "FG001", "title": "Placebo", "description": "Placebo once daily"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "339"}, {"groupId": "FG001", "numSubjects": "336"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "334"}, {"groupId": "FG001", "numSubjects": "328"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "5"}, {"groupId": "FG001", "numSubjects": "8"}]}], "dropWithdraws": [{"type": "Technical Problems", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "0"}]}, {"type": "Protocol deviation", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "1"}]}, {"type": "Physician Decision", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "1"}]}, {"type": "Death", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "1"}]}, {"type": "Adverse Event", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "2"}]}, {"type": "Subject/Guardian Decision", "reasons": [{"groupId": "FG000", "numSubjects": "3"}, {"groupId": "FG001", "numSubjects": "3"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "QAW039", "description": "QAW039 once daily"}, {"id": "BG001", "title": "Placebo", "description": "Placebo once daily"}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "339"}, {"groupId": "BG001", "value": "336"}, {"groupId": "BG002", "value": "675"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "Years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "48.1", "spread": "15.15"}, {"groupId": "BG001", "value": "47.7", "spread": "15.40"}, {"groupId": "BG002", "value": "47.9", "spread": "15.26"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "217"}, {"groupId": "BG001", "value": "216"}, {"groupId": "BG002", "value": "433"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "122"}, {"groupId": "BG001", "value": "120"}, {"groupId": "BG002", "value": "242"}]}]}]}, {"title": "Race/Ethnicity, Customized", "paramType": "NUMBER", "unitOfMeasure": "Participants", "classes": [{"title": "Caucasian", "categories": [{"measurements": [{"groupId": "BG000", "value": "274"}, {"groupId": "BG001", "value": "281"}, {"groupId": "BG002", "value": "555"}]}]}, {"title": "Black", "categories": [{"measurements": [{"groupId": "BG000", "value": "18"}, {"groupId": "BG001", "value": "12"}, {"groupId": "BG002", "value": "30"}]}]}, {"title": "Asian", "categories": [{"measurements": [{"groupId": "BG000", "value": "39"}, {"groupId": "BG001", "value": "34"}, {"groupId": "BG002", "value": "73"}]}]}, {"title": "Native American", "categories": [{"measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "1"}]}]}, {"title": "Pacific Islander", "categories": [{"measurements": [{"groupId": "BG000", "value": "2"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "2"}]}]}, {"title": "Unknown", "categories": [{"measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "3"}, {"groupId": "BG002", "value": "3"}]}]}, {"title": "Other", "categories": [{"measurements": [{"groupId": "BG000", "value": "5"}, {"groupId": "BG001", "value": "6"}, {"groupId": "BG002", "value": "11"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Change From Baseline in Pre-dose FEV1 at Week 12", "description": "Forced Expiratory Volume in one second (FEV1) is calculated as the volume of air forcibly exhaled in one second as measured by a spirometer. Baseline is defined as the last available FEV1 measurement taken prior to the first dose of randomized study drug.", "populationDescription": "Full analysis set (FAS): all randomized patients who received at least one dose of study medication. Patients in the FAS were analyzed according to the treatment they were assigned to at randomization.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "Liters", "timeFrame": "Week 12", "groups": [{"id": "OG000", "title": "QAW039", "description": "QAW039 once daily"}, {"id": "OG001", "title": "Placebo", "description": "Placebo once daily"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "339"}, {"groupId": "OG001", "value": "336"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.112", "spread": "0.0167"}, {"groupId": "OG001", "value": "0.071", "spread": "0.0169"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "nonInferiorityType": "SUPERIORITY", "pValue": "0.088", "statisticalMethod": "ANCOVA", "paramType": "Mean Difference (Net)", "paramValue": "0.0238", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.006", "ciUpperLimit": "0.088"}]}, {"type": "SECONDARY", "title": "Change From Baseline in Daytime Asthma Symptom Score", "description": "Daytime asthma symptoms are evaluated through four questions and each of them will be rated on a scale of 0 to 6. Higher scores indicate more severe asthma-related symptoms. A mean score will be calculated for the responses to 4 questions.", "populationDescription": "Full analysis set (FAS): all randomized patients who received at least one dose of study medication. Patients in the FAS were analyzed according to the treatment they were assigned to at randomization.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "Score", "timeFrame": "12 weeks", "groups": [{"id": "OG000", "title": "QAW039", "description": "QAW039 once daily"}, {"id": "OG001", "title": "Placebo", "description": "Placebo once daily"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "339"}, {"groupId": "OG001", "value": "336"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-0.56", "spread": "0.036"}, {"groupId": "OG001", "value": "-0.51", "spread": "0.037"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "nonInferiorityType": "SUPERIORITY", "pValue": "0.278", "statisticalMethod": "ANCOVA", "paramType": "Mean Difference (Net)", "paramValue": "-0.06", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.16", "ciUpperLimit": "0.05"}]}, {"type": "SECONDARY", "title": "Change From Baseline in Daily Use of SABA", "description": "Daily use of SABA (the number of rescue medication puffs taken in the previous 12 hours) was recorded using a patient electronic diary (referred to as eDiary or eDiary/ePEF). Patients were instructed to routinely complete the patient diary twice daily - at the same time each morning and each evening, approximately 12 hours apart.", "populationDescription": "Full analysis set (FAS): all randomized patients who received at least one dose of study medication. Patients in the FAS were analyzed according to the treatment they were assigned to at randomization.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "Number of puffs", "timeFrame": "12 weeks", "groups": [{"id": "OG000", "title": "QAW039", "description": "QAW039 once daily"}, {"id": "OG001", "title": "Placebo", "description": "Placebo once daily"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "339"}, {"groupId": "OG001", "value": "336"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-1.11", "spread": "0.075"}, {"groupId": "OG001", "value": "-1.02", "spread": "0.076"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "nonInferiorityType": "SUPERIORITY", "pValue": "0.429", "statisticalMethod": "ANCOVA", "paramType": "Mean Difference (Net)", "paramValue": "-0.08", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.30", "ciUpperLimit": "0.13"}]}, {"type": "SECONDARY", "title": "Change From Baseline in Asthma Quality of Life (AQLQ+12) Score", "description": "AQLQ is a 32-item instrument administered as a self-assessment. AQLQ+12 is a modified version of AQLQ developed to measure functional impairments of participants aged 12-70 years. It is divided into 4 domains: activity limitation, symptoms, emotional function, and environmental stimuli. Participants were asked to recall their experiences during the last 2 weeks and respond to each question on a 7-point scale (1=severe impairment, 7=no impairment), where higher scores indicated \"better quality of life.\" Overall AQLQ+12 score is the mean of all 32 responses.", "populationDescription": "Full analysis set (FAS): all randomized patients who received at least one dose of study medication. Patients in the FAS were analyzed according to the treatment they were assigned to at randomization.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "units on a scale", "timeFrame": "Week 12", "groups": [{"id": "OG000", "title": "QAW039", "description": "QAW039 once daily"}, {"id": "OG001", "title": "Placebo", "description": "Placebo once daily"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "339"}, {"groupId": "OG001", "value": "336"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.91", "spread": "0.048"}, {"groupId": "OG001", "value": "0.89", "spread": "0.049"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "nonInferiorityType": "SUPERIORITY", "pValue": "0.777", "statisticalMethod": "ANCOVA", "paramType": "Mean Difference (Net)", "paramValue": "0.069", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.12", "ciUpperLimit": "0.15"}]}]}, "adverseEventsModule": {"frequencyThreshold": "1", "timeFrame": "After signing informed consent to 30 days after last dose", "eventGroups": [{"id": "EG000", "title": "QAW039 150 mg", "description": "QAW039 150 mg", "deathsNumAffected": 0, "deathsNumAtRisk": 339, "seriousNumAffected": 1, "seriousNumAtRisk": 339, "otherNumAffected": 94, "otherNumAtRisk": 339}, {"id": "EG001", "title": "Placebo", "description": "Placebo", "deathsNumAffected": 1, "deathsNumAtRisk": 336, "seriousNumAffected": 5, "seriousNumAtRisk": 336, "otherNumAffected": 102, "otherNumAtRisk": 336}], "seriousEvents": [{"term": "Upper respiratory tract infection bacterial", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 339}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 336}]}, {"term": "Electrocardiogram T wave inversion", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 339}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 336}]}, {"term": "Astrocytoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 339}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 336}]}, {"term": "Asthma", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 339}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 336}]}, {"term": "Pulmonary embolism", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 339}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 336}]}], "otherEvents": [{"term": "Diarrhoea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 339}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 336}]}, {"term": "Fatigue", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 339}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 336}]}, {"term": "Acute sinusitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 4, "numAtRisk": 339}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 336}]}, {"term": "Bronchitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 12, "numAtRisk": 339}, {"groupId": "EG001", "numAffected": 10, "numAtRisk": 336}]}, {"term": "Nasopharyngitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 13, "numAtRisk": 339}, {"groupId": "EG001", "numAffected": 12, "numAtRisk": 336}]}, {"term": "Rhinitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 339}, {"groupId": "EG001", "numAffected": 5, "numAtRisk": 336}]}, {"term": "Upper respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 6, "numAtRisk": 339}, {"groupId": "EG001", "numAffected": 10, "numAtRisk": 336}]}, {"term": "Upper respiratory tract infection bacterial", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 5, "numAtRisk": 339}, {"groupId": "EG001", "numAffected": 5, "numAtRisk": 336}]}, {"term": "Viral upper respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 7, "numAtRisk": 339}, {"groupId": "EG001", "numAffected": 6, "numAtRisk": 336}]}, {"term": "Blood creatine phosphokinase increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 339}, {"groupId": "EG001", "numAffected": 5, "numAtRisk": 336}]}, {"term": "Arthralgia", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 339}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 336}]}, {"term": "Back pain", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 4, "numAtRisk": 339}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 336}]}, {"term": "Headache", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 6, "numAtRisk": 339}, {"groupId": "EG001", "numAffected": 7, "numAtRisk": 336}]}, {"term": "Asthma", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 43, "numAtRisk": 339}, {"groupId": "EG001", "numAffected": 45, "numAtRisk": 336}]}, {"term": "Cough", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 339}, {"groupId": "EG001", "numAffected": 5, "numAtRisk": 336}]}, {"term": "Nasal congestion", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 339}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 336}]}, {"term": "Rhinitis allergic", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 12, "numAtRisk": 339}, {"groupId": "EG001", "numAffected": 6, "numAtRisk": 336}]}, {"term": "Hypertension", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 339}, {"groupId": "EG001", "numAffected": 5, "numAtRisk": 336}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true, "otherDetails": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial."}, "pointOfContact": {"title": "Study Director", "organization": "Novartis Pharmaceutical", "email": "Novartis.email@novartis.com", "phone": "862-778-8300"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "Prot", "hasProtocol": true, "hasSap": false, "hasIcf": false, "label": "Study Protocol", "date": "2017-05-10", "uploadDate": "2020-01-30T10:22", "filename": "Prot_001.pdf", "size": 2645867}, {"typeAbbrev": "SAP", "hasProtocol": false, "hasSap": true, "hasIcf": false, "label": "Statistical Analysis Plan", "date": "2019-08-25", "uploadDate": "2020-01-30T10:22", "filename": "SAP_000.pdf", "size": 814599}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000001249", "term": "Asthma"}], "ancestors": [{"id": "D000001982", "term": "Bronchial Diseases"}, {"id": "D000012140", "term": "Respiratory Tract Diseases"}, {"id": "D000008173", "term": "Lung Diseases, Obstructive"}, {"id": "D000008171", "term": "Lung Diseases"}, {"id": "D000012130", "term": "Respiratory Hypersensitivity"}, {"id": "D000006969", "term": "Hypersensitivity, Immediate"}, {"id": "D000006967", "term": "Hypersensitivity"}, {"id": "D000007154", "term": "Immune System Diseases"}], "browseLeaves": [{"id": "M4556", "name": "Asthma", "asFound": "Asthma", "relevance": "HIGH"}, {"id": "M5258", "name": "Bronchial Diseases", "relevance": "LOW"}, {"id": "M14977", "name": "Respiratory Tract Diseases", "relevance": "LOW"}, {"id": "M11168", "name": "Lung Diseases", "relevance": "LOW"}, {"id": "M11170", "name": "Lung Diseases, Obstructive", "relevance": "LOW"}, {"id": "M10018", "name": "Hypersensitivity", "relevance": "LOW"}, {"id": "M14967", "name": "Respiratory Hypersensitivity", "relevance": "LOW"}, {"id": "M10020", "name": "Hypersensitivity, Immediate", "relevance": "LOW"}, {"id": "M10200", "name": "Immune System Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC20", "name": "Immune System Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}}, "hasResults": true}